NYSE:MCKHealthcare
Analysts’ Backing of 2027 Targets Might Change The Case For Investing In McKesson (MCK)
In recent days, McKesson reported a mixed quarter but reinforced its long‑term plans, while major Wall Street banks reaffirmed positive views on the company’s outlook and multi-year guidance.
At the same time, ongoing insider share sales and assessments of the stock as modestly overvalued have sharpened investor focus on how credible its fiscal 2027 ambitions really are.
We’ll now examine how analysts’ support for McKesson’s fiscal 2027 guidance could influence the company’s existing...